Contact this trialFirst, we need to learn more about you.
CAR T-cell Therapy
Armored CAR T Cells for Blood Cancer
Recruiting1 awardPhase 1
New York, New York
This trial is testing different doses of specially prepared cells to see if they are safe for patients with cancer that has progressed after standard therapy. If the patients meet all eligibility criteria, they can be enrolled a second time to receive treatment in a higher dose level cohort.
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service.
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.
By clicking start, you agree to our
terms of service